Axogen, Inc. (AXGN)
NASDAQ: AXGN · Real-Time Price · USD
30.08
+0.73 (2.49%)
Dec 17, 2025, 10:25 AM EST - Market open
Axogen Employees
As of December 31, 2024, Axogen had 452 total employees, including 451 full-time and 1 part-time employees. The number of employees increased by 24 or 5.61% compared to the previous year.
Employees
452
Change (1Y)
24
Growth (1Y)
5.61%
Revenue / Employee
$475,020
Profits / Employee
-$4,639
Market Cap
1.39B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 452 | 24 | 5.61% |
| Dec 31, 2023 | 428 | 32 | 8.08% |
| Dec 31, 2022 | 396 | -55 | -12.20% |
| Dec 31, 2021 | 451 | 83 | 22.55% |
| Dec 31, 2020 | 368 | -26 | -6.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AXGN News
- 13 days ago - Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx) - GlobeNewsWire
- 13 days ago - FDA approves Axogen's nerve repair graft - Reuters
- 15 days ago - Avance Nerve Graft FDA Verdict Approaches, Why Investors Are Watching Axogen - Seeking Alpha
- 5 weeks ago - Wasatch Micro Cap Value Fund Q3 2025 Contributors And Detractors - Seeking Alpha
- 6 weeks ago - Axogen, Inc. (AXGN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Axogen, Inc. Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Axogen, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – AXGN - Business Wire
- 2 months ago - AXGN Investors Have Opportunity to Join Axogen, Inc. Fraud Investigation with the Schall Law Firm - Business Wire